John Poyhonen
Overview
John Poyhonen received an average of $3M in total compensation, including $413K in salary, at Heron Therapeutics from 2019 to 2021. John Poyhonen also received an average of $1M at Senomyx from 2006 to 2017.
- 2021
- 2020
- 2019
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
Heron TherapeuticsPresident and Chief Commercial Officer
Heron TherapeuticsPresident and Chief Commercial Officer
Heron TherapeuticsExecutive Vice President, Chief Commercial Officer
SenomyxPresident, Chief Executive Officer
SenomyxPresident, Chief Executive Officer
SenomyxPresident, Chief Executive Officer
SenomyxPresident, Chief Executive Officer
SenomyxPresident, Chief Executive Officer
SenomyxPresident, Chief Executive Officer
SenomyxPresident, Chief Executive Officer and Former Chief Operating Officer
Source: SEC filings on April 25, 2022, April 22, 2021, April 23, 2020, April 9, 2018, April 8, 2016, April 8, 2015, April 15, 2014, April 24, 2013, April 19, 2012, April 14, 2011, April 22, 2010, and April 20, 2009.
Related executives
We found 28 more executives who work or worked at Heron Therapeutics and Senomyx.
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
Robert Rosen
Heron Therapeutics
Former President
Sharon Wicker
Senomyx
Senior Vice President and Chief Commercial Development Officer
Catherine Lee
Senomyx